Can marine-derived fungus Neosartorya siamensis KUFA 0017 extract and its secondary metabolites enhance antitumor activity of doxorubicin? An in vitro survey unveils interactions against lung cancer cells

Doxorubicin (Dox) is one of the most successful anticancer drugs in use. However, chemoresistance is one of the main limitations that patients face. Therefore, development of new strategies to improve the efficacy of Dox is needed. Marine-derived fungi are especially promising sources of new antican...

Full description

Bibliographic Details
Main Author: Ramos, A.A. (author)
Other Authors: Castro-Carvalho, B. (author), Prata-Sena, M. (author), Malhão, F. (author), Buttachon, S. (author), Dethoup, T. (author), Kijjoa, A. (author), Rocha, E. (author)
Format: article
Language:eng
Published: 2020
Subjects:
Neosartorya siamensis
doxorubicin
drug combination
in vitro anticancer activity
marine-derived compounds
marine-derived fungal extract
non-small cell lung cancer
Online Access:https://hdl.handle.net/10216/130488
Country:Portugal
Oai:oai:repositorio-aberto.up.pt:10216/130488

Internet

https://hdl.handle.net/10216/130488

Similar Items